Quick Answer
Galera Therapeutics, Inc. reported Stockholders Equity of $3.97 million for fiscal year 2025.
Galera Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.97M | +102.7% |
| 2024 | -$148.04M | -12.8% |
| 2023 | -$131.19M | -20.2% |
| 2022 | -$109.18M | -88.2% |
| 2021 | -$58.00M | -1048.1% |
| 2020 | $6.12M | -91.2% |
| 2019 | $69.61M | +166.4% |
| 2018 | -$104.82M | -37.7% |
| 2017 | -$76.11M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$149.22M | -4.3% | -0.9% |
| June 30, 2025 | -$147.94M | -7.2% | -0.5% |
| March 31, 2025 | -$147.23M | -9.3% | +0.5% |
| December 31, 2024 | -$148.04M | -12.8% | -3.5% |
| September 30, 2024 | -$143.06M | -13.0% | -3.6% |
| June 30, 2024 | -$138.03M | -20.0% | -2.5% |
| March 31, 2024 | -$134.69M | -38.0% | -2.7% |
| December 31, 2023 | -$131.19M | -20.2% | -3.7% |
- Galera Therapeutics, Inc. showed an increase of +102.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Galera Therapeutics, Inc.’s stockholders equity has grown by 105.2% (from -$76.11 million to $3.97 million).
- The most recent figure is from Galera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: